We're grateful for the incredibly well organized and impactful volunteer experience the Variant Bio team had at @FoodLifeline last week. Hunger does not have to happen.
Variant Bio celebrated #PrideMonth yesterday by increasing awareness of diversity through a game of trivia focused on the accomplishments and struggles of LGBTQIA+ people in the USA and around the world
Those who know me know that creating new therapeutic options for fibrotic disease is one of my passions, and I’m really excited that Variant Bio is taking this genetics-driven approach to understanding why some individuals with fibrosis progress rapidly - and why others don’t.
Excited to announce that @VariantBio and @BilhiGenetics are embarking on a new partnership in Uganda to identify the genetic risk factors for liver fibrosis: https://t.co/ZiRrKgq8tM
Our Chief R&D Officer, Tom Rush (@tsrush3), explains how @VariantBio is uniquely positioned to better understand and treat disease: https://t.co/gLsssmallS
We are thrilled to welcome Dr. Laura Yerges-Armstrong (@lmayerges) to the team @VariantBio! Previously, Laura was Senior Director, Head of Statistical Genetics and Genomic Data Sciences at GSK, and Assistant Professor of Medicine at the University of Maryland.
Check out the podcast Variant's CSO @kajawasik gave on the power of genetic diversity in drug development, now available on @audible_com: https://t.co/H4JkQaM8Ew
Variant Bio is thrilled to welcome our new Chief R&D Officer, Dr. Tom Rush @tsrush3, to the team. Tom draws on extensive experience in drug discovery and development at GSK, the ATOM Consortium, Merck, and Wyeth/Pfizer, and we are excited to have him lead our expanding pipeline!
So much to tune into today, including this talk starting 5pm EST by Variant's Lead Cultural Anthropologist, Dr. Sarah LeBaron von Baeyer, on our unique benefit sharing approach: https://t.co/Hxc3vL7pDD
We are thrilled to announce our new VP of Research, Dr. Heather Arnett (@heatheralane)! Heather's 13+ years experience working in genomic drug discovery at Amgen will be invaluable to Variant. Welcome to the team!!
Such a fantastic resource for the whole field - I'm thrilled to have been a part of this collaboration! Many congratulations to the Kaminski and Rosas labs! #CureIPF
1/n The #IPFCellAtlas is finally out! We profiled 312,928 cells from 32 IPF, 28 controls, 18 COPD lungs using @10xGenomics#scRNAseq & identified previously unidentified populations of epithelial & endothelial cells enriched in IPF #CureIPF https://t.co/nrNp2wXLzA
We have lost Dr. Steven Schwartz to Covid19. Many know Steve as @UW professor of Pathology and director of the Cardiovascular Pathology Training Grant. It’s a sad day
This maybe extremely important for herd immunity modeling. Seems that non-human primates do develop protective immunity to #COVID19! https://t.co/wyjSHnRykr
Wow! LARGEST EVER report of #PulmonaryFibrosis genetics is out (4124 IPF & 17,182 controls) confirms previously discovered genetic associations (#MUC5BRules) & finds new ones - Kudos @LouiseVwain and team!! #CureIPF#Genetics https://t.co/7utQoT2Yl1
The #IPFCellAtlas is now life on @biorxivpreprint - Just in time for Pulmonary Fibrosis Awareness Month. A Kaminski / Rosas production funded by @3LakesPartners @nih_nhlbi #CureIPF#PFAM2019#TrumanWasRight populationshttps://www.biorxiv.org/content/10.1101/759902v1